← Eichor
Condition: Haploidentical Allogeneic Hematopoietic Stem Cell Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Haploidentical Allogeneic Hematopoietic Stem Cell Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Ce
Phase 1 · 21 location(s) · TScan Therapeutics, Inc. · NCT05473910Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Chil
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07693881A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05027945Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transpl
Phase 3 · 26 location(s) · TScan Therapeutics, Inc. · NCT07702578Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01861106BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT04187105A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an
Phase 2 · 6 location(s) · Memorial Sloan Kettering Cancer Center · NCT05736419Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06089850Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
NA · 2 location(s) · Baylor College of Medicine · NCT01189786Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04339777Modified Second Haplo-transplantation for Graft Failure
NA · 1 location(s) · Peking University People's Hospital · NCT06512545Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With
Phase 2 · 35 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05126849
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.